• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶酶体酸性脂肪酶:在正常和动脉粥样硬化胆固醇代谢的十字路口。

Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism.

机构信息

Department of Medicine, Centre for Heart Lung Innovation, Providence Health Care Research Institute at St. Paul's Hospital, University of British Columbia Vancouver, BC, Canada.

出版信息

Front Cell Dev Biol. 2015 Feb 2;3:3. doi: 10.3389/fcell.2015.00003. eCollection 2015.

DOI:10.3389/fcell.2015.00003
PMID:25699256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4313778/
Abstract

Unregulated cellular uptake of apolipoprotein B-containing lipoproteins in the arterial intima leads to the formation of foam cells in atherosclerosis. Lysosomal acid lipase (LAL) plays a crucial role in both lipoprotein lipid catabolism and excess lipid accumulation as it is the primary enzyme that hydrolyzes cholesteryl esters derived from both low density lipoprotein (LDL) and modified forms of LDL. Evidence suggests that as atherosclerosis progresses, accumulation of excess free cholesterol in lysosomes leads to impairment of LAL activity, resulting in accumulation of cholesteryl esters in the lysosome as well as the cytosol in foam cells. Impaired metabolism and release of cholesterol from lysosomes can lead to downstream defects in ATP-binding cassette transporter A1 regulation, needed to offload excess cholesterol from plaque foam cells. This review focuses on the role LAL plays in normal cholesterol metabolism and how the associated changes in its enzymatic activity may ultimately contribute to atherosclerosis progression.

摘要

未调节的细胞摄取富含载脂蛋白 B 的脂蛋白在动脉内膜中导致泡沫细胞形成在动脉粥样硬化中。溶酶体酸性脂肪酶(LAL)在脂蛋白脂质代谢和脂质积累过多中起着至关重要的作用,因为它是水解来自低密度脂蛋白(LDL)和 LDL 修饰形式的胆固醇酯的主要酶。有证据表明,随着动脉粥样硬化的进展,溶酶体中过量游离胆固醇的积累导致 LAL 活性受损,导致胆固醇酯在溶酶体以及泡沫细胞的细胞质中积累。溶酶体中胆固醇的代谢和释放受损可导致下游三磷酸腺苷结合盒转运蛋白 A1 调节缺陷,需要从斑块泡沫细胞中卸载过量胆固醇。本综述重点介绍了 LAL 在正常胆固醇代谢中的作用,以及其酶活性的相关变化如何最终导致动脉粥样硬化的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dcb/4313778/e582a1d9ec57/fcell-03-00003-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dcb/4313778/8ffe6568fe84/fcell-03-00003-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dcb/4313778/bca301451498/fcell-03-00003-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dcb/4313778/e582a1d9ec57/fcell-03-00003-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dcb/4313778/8ffe6568fe84/fcell-03-00003-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dcb/4313778/bca301451498/fcell-03-00003-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dcb/4313778/e582a1d9ec57/fcell-03-00003-g0003.jpg

相似文献

1
Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism.溶酶体酸性脂肪酶:在正常和动脉粥样硬化胆固醇代谢的十字路口。
Front Cell Dev Biol. 2015 Feb 2;3:3. doi: 10.3389/fcell.2015.00003. eCollection 2015.
2
Macrophage-mediated cholesterol handling in atherosclerosis.巨噬细胞介导的动脉粥样硬化中的胆固醇处理
J Cell Mol Med. 2016 Jan;20(1):17-28. doi: 10.1111/jcmm.12689. Epub 2015 Oct 23.
3
Mechanisms of foam cell formation in atherosclerosis.动脉粥样硬化中泡沫细胞形成的机制。
J Mol Med (Berl). 2017 Nov;95(11):1153-1165. doi: 10.1007/s00109-017-1575-8. Epub 2017 Aug 7.
4
Foam cells in atherosclerosis.动脉粥样硬化中的泡沫细胞。
Clin Chim Acta. 2013 Sep 23;424:245-52. doi: 10.1016/j.cca.2013.06.006. Epub 2013 Jun 16.
5
Sortilin promotes macrophage cholesterol accumulation and aortic atherosclerosis through lysosomal degradation of ATP-binding cassette transporter A1 protein.Sortilin 通过溶酶体降解 ABCA1 蛋白促进巨噬细胞胆固醇蓄积和主动脉粥样硬化。
Acta Biochim Biophys Sin (Shanghai). 2019 May 23;51(5):471-483. doi: 10.1093/abbs/gmz029.
6
Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages.鼠源巨噬细胞中,鼠尾草(Salvia plebeia)提取物拮抗泡沫细胞形成并促进胆固醇外流。
Int J Mol Med. 2012 Nov;30(5):1105-12. doi: 10.3892/ijmm.2012.1103. Epub 2012 Aug 20.
7
LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport In Vitro and In Vivo.溶酶体酸性脂肪酶(LAL)在体外和体内促进胆固醇逆向转运。
Arterioscler Thromb Vasc Biol. 2018 May;38(5):1191-1201. doi: 10.1161/ATVBAHA.117.310507. Epub 2018 Mar 29.
8
ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells.内膜型动脉平滑肌细胞中ATP结合盒转运蛋白A1的表达及载脂蛋白A-I结合功能受损。
Circulation. 2009 Jun 30;119(25):3223-31. doi: 10.1161/CIRCULATIONAHA.108.841130. Epub 2009 Jun 15.
9
The role of microscopy in understanding atherosclerotic lysosomal lipid metabolism.显微镜检查在理解动脉粥样硬化溶酶体脂质代谢中的作用。
Microsc Microanal. 2003 Feb;9(1):54-67. doi: 10.1017/S1431927603030010.
10
CRISPR/Cas9-Mediated Gene Editing in Human iPSC-Derived Macrophage Reveals Lysosomal Acid Lipase Function in Human Macrophages-Brief Report.CRISPR/Cas9介导的人类诱导多能干细胞衍生巨噬细胞基因编辑揭示了溶酶体酸性脂肪酶在人类巨噬细胞中的功能——简要报告
Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2156-2160. doi: 10.1161/ATVBAHA.117.310023. Epub 2017 Sep 7.

引用本文的文献

1
LIPL-1 and LIPL-2 are TCER-1-regulated Lysosomal Lipases with Distinct Roles in Immunity and Fertility.LIPL-1和LIPL-2是受TCER-1调节的溶酶体脂肪酶,在免疫和生育中发挥不同作用。
bioRxiv. 2025 Jul 18:2025.07.14.664648. doi: 10.1101/2025.07.14.664648.
2
Glucosylated cholesterol accumulates in atherosclerotic lesions and impacts macrophage immune response.糖基化胆固醇在动脉粥样硬化病变中蓄积,并影响巨噬细胞免疫反应。
J Lipid Res. 2025 Jun;66(6):100825. doi: 10.1016/j.jlr.2025.100825. Epub 2025 May 15.
3
Key Mechanisms in Lysosome Stability, Degradation and Repair.

本文引用的文献

1
Induction of lysosomal biogenesis in atherosclerotic macrophages can rescue lipid-induced lysosomal dysfunction and downstream sequelae.诱导动脉粥样硬化巨噬细胞中的溶酶体生物合成可挽救脂质诱导的溶酶体功能障碍及下游后遗症。
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1942-1952. doi: 10.1161/ATVBAHA.114.303342. Epub 2014 Jul 24.
2
Reversal of advanced disease in lysosomal acid lipase deficient mice: a model for lysosomal acid lipase deficiency disease.溶酶体酸性脂肪酶缺乏症小鼠的晚期疾病逆转:溶酶体酸性脂肪酶缺乏症模型。
Mol Genet Metab. 2014 Jul;112(3):229-41. doi: 10.1016/j.ymgme.2014.04.006. Epub 2014 May 4.
3
溶酶体稳定性、降解及修复的关键机制
Mol Cell Biol. 2025;45(5):212-224. doi: 10.1080/10985549.2025.2494762. Epub 2025 May 9.
4
Oxidized LDL stimulates PKM2-mediated mtROS production and phagocytosis.氧化型低密度脂蛋白刺激丙酮酸激酶M2介导的线粒体活性氧生成和吞噬作用。
J Lipid Res. 2025 May;66(5):100809. doi: 10.1016/j.jlr.2025.100809. Epub 2025 Apr 16.
5
Down-regulation of ATP8B2 in Foam Cells Inhibits Autophagic Flux and ox-LDL Degradation in Atherosclerosis.泡沫细胞中ATP8B2的下调抑制动脉粥样硬化中的自噬通量和氧化型低密度脂蛋白降解。
Cell Biochem Biophys. 2025 Mar 28. doi: 10.1007/s12013-025-01728-z.
6
Lysosome Functions in Atherosclerosis: A Potential Therapeutic Target.溶酶体在动脉粥样硬化中的功能:一个潜在的治疗靶点。
Cells. 2025 Jan 24;14(3):183. doi: 10.3390/cells14030183.
7
Altered lipid homeostasis and autophagy precipitate diffuse alveolar hemorrhage in murine lupus.脂质稳态改变和自噬促使小鼠狼疮发生弥漫性肺泡出血。
Autophagy Rep. 2024;3(1). doi: 10.1080/27694127.2024.2379193. Epub 2024 Jul 23.
8
Intracellular endothelial cell metabolism in vascular function and dysfunction.血管功能与功能障碍中的细胞内内皮细胞代谢
Trends Endocrinol Metab. 2024 Dec 12. doi: 10.1016/j.tem.2024.11.004.
9
An update on ox-LDL-inducing vascular smooth muscle cell-derived foam cells in atherosclerosis.氧化低密度脂蛋白诱导动脉粥样硬化中血管平滑肌细胞源性泡沫细胞的研究进展
Front Cell Dev Biol. 2024 Oct 25;12:1481505. doi: 10.3389/fcell.2024.1481505. eCollection 2024.
10
Immune Implications of Cholesterol-Containing Lipid Nanoparticles.载脂蛋白胆固醇脂质纳米颗粒的免疫相关性。
ACS Nano. 2024 Oct 22;18(42):28480-28501. doi: 10.1021/acsnano.4c06369. Epub 2024 Oct 10.
Self-eating in the plaque: what macrophage autophagy reveals about atherosclerosis.
斑块中的自噬:巨噬细胞自噬对动脉粥样硬化的启示。
Trends Endocrinol Metab. 2014 May;25(5):225-34. doi: 10.1016/j.tem.2014.03.010. Epub 2014 Apr 17.
4
Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis.平滑肌细胞在人类动脉粥样硬化中胆固醇蓄积和巨噬细胞样细胞形成中的作用。
Circulation. 2014 Apr 15;129(15):1551-9. doi: 10.1161/CIRCULATIONAHA.113.005015. Epub 2014 Jan 30.
5
FoxO1 controls lysosomal acid lipase in adipocytes: implication of lipophagy during nutrient restriction and metformin treatment.FoxO1 调控脂肪细胞中的溶酶体酸性脂肪酶:营养限制和二甲双胍治疗期间脂噬的作用。
Cell Death Dis. 2013 Oct 17;4(10):e861. doi: 10.1038/cddis.2013.404.
6
Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia.外显子组测序和定向临床表型诊断表现为常染色体隐性高胆固醇血症的胆固醇酯贮积症。
Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2909-14. doi: 10.1161/ATVBAHA.113.302426. Epub 2013 Sep 26.
7
TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop.TFEB 通过饥饿诱导的自调节环控制细胞脂质代谢。
Nat Cell Biol. 2013 Jun;15(6):647-58. doi: 10.1038/ncb2718. Epub 2013 Apr 21.
8
Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease.胆固醇酯贮积症:135 例报道患者的发现回顾——一种被低估的疾病。
J Hepatol. 2013 Jun;58(6):1230-43. doi: 10.1016/j.jhep.2013.02.014. Epub 2013 Feb 26.
9
Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups.载脂蛋白 E 代谢障碍症常见 LIPA E8SJM 突变(c.894G>A)在不同种族和民族中的频率。
Hepatology. 2013 Sep;58(3):958-65. doi: 10.1002/hep.26327. Epub 2013 Jul 29.
10
Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease.重组人溶酶体酸性脂肪酶治疗胆固醇酯贮积症患者的临床疗效和安全性特征。
Hepatology. 2013 Sep;58(3):950-7. doi: 10.1002/hep.26289. Epub 2013 Mar 28.